In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.
As part of the 10-year anniversary events, ECDC hosted a scientific seminar to discuss some of the pressing public health challenges to Europe, such as antimicrobial resistance and influenza.
The ERLTB-Net sub-network of reference laboratories from EU/EEA Member States supports harmonisation of methods and laboratory capacity for tuberculosis diagnosis, antimicrobial susceptibility testing and typing in the EU/EEA.
The emergence of cholera in Haiti once again reminds us of the ferocity with which infectious diseases can strike and of the complex interactions of emerging infectious diseases with social conditions, human migration, and the ecosystem.
Location:Hilton Am Stadtpark, Vienna, Austria
Organized by:International Society for Infectious Diseases (ISID)